Registration for PeproTech.com is no longer available. To order your PeproTech products online, register or logon to ThermoFisher.com.

Resources & Support

References

First Author
Maor, Y
Title
Liraglutide-Induced Hepatotoxicity.
Citation
Biomedicines; 2021 Jan 22; 9(2)
PubMed ID
Product Cited
Cross-Reactivity
Applications
Human
ELISA
Human
ELISA
Human
ELISA
Human
ELISA
Human
ELISA
Human
ELISA
First Author
Waldeck, S
Title
CCL5 mediates target-kinase independent resistance to FLT3 inhibitors in FLT3-ITD-positive AML.
Citation
Molecular oncology; 2020 Apr; 14(4) pg779-794
PubMed ID
Product Cited
Cross-Reactivity
Applications
Human
in vitro
Human
in vitro
Human
ELISA
Human
ELISA
First Author
Chu, M
Title
Cyclic peptide *CRRETAWAC* attenuates fibronectin-induced cytokine secretion of human airway smooth muscle cells by inhibiting FAK and p38 MAPK.
Citation
Journal of cellular and molecular medicine; 2017 Oct; 21(10) pg2535-2541
PubMed ID
Product Cited
Cross-Reactivity
Applications
Human
in vitro
Human
ELISA
Human
ELISA
First Author
Ahmed, S
Title
TRIF-mediated TLR3 and TLR4 signaling is negatively regulated by ADAM15.
Citation
Journal of immunology (Baltimore, Md. : 1950); 2013 Mar 1; 190(5) pg2217-28
PubMed ID
Product Cited
Cross-Reactivity
Applications
Human
ELISA
Human
ELISA
First Author
Butt, A Q
Title
14-3-3ε and 14-3-3σ inhibit Toll-like receptor (TLR)-mediated proinflammatory cytokine induction.
Citation
The Journal of Biological Chemistry; 2012 Nov 9; 287(46) pg38665-79
PubMed ID
Product Cited
Cross-Reactivity
Applications
Human
ELISA
Human
ELISA
Human
ELISA
Human
ELISA
Human
ELISA
Human
ELISA
First Author
Elsawa, S F
Title
Comprehensive analysis of tumor microenvironment cytokines in Waldenstrom macroglobulinemia identifies CCL5 as a novel modulator of IL-6 activity.
Citation
Blood; 2011 Nov 17; 118(20) pg5540-9
PubMed ID
Product Cited
Cross-Reactivity
Applications
Human
ELISA
Human
ELISA
Human
in vitro
First Author
Nasreddine, N
Title
Advanced glycation end products inhibit both infection and transmission in trans of HIV-1 from monocyte-derived dendritic cells to autologous T cells.
Citation
Journal of immunology (Baltimore, Md. : 1950); 2011 May 15; 186(10) pg5687-95
PubMed ID
Product Cited
Cross-Reactivity
Applications
Human
in vitro
Human
in vitro
First Author
Strassheim, D
Title
Prostacyclin inhibits IFN-gamma-stimulated cytokine expression by reduced recruitment of CBP/p300 to STAT1 in a SOCS-1-independent manner.
Citation
Journal of immunology (Baltimore, Md. : 1950); 2009 Dec 1; 183(11) pg6981-8
PubMed ID
Product Cited
Cross-Reactivity
Applications
Human
ELISA
Human
ELISA
Human
ELISA
Human
ELISA
Human
ELISA
Human
ELISA
First Author
Wilcox, R A
Title
Monocytes promote tumor cell survival in T-cell lymphoproliferative disorders and are impaired in their ability to differentiate into mature dendritic cells.
Citation
Blood; 2009 Oct 1; 114(14) pg2936-44
PubMed ID
Product Cited
Cross-Reactivity
Applications
Human
ELISA
First Author
Mateo, T
Title
Angiotensin II-induced mononuclear leukocyte interactions with arteriolar and venular endothelium are mediated by the release of different CC chemokines.
Citation
Journal of immunology (Baltimore, Md. : 1950); 2006 May 1; 176(9) pg5577-86
PubMed ID
Product Cited
Cross-Reactivity
Applications
Human
ELISA
Human
ELISA
Human
ELISA
Human
ELISA
Human
ELISA
Human
ELISA
Human
ELISA
Human
ELISA
Human
ELISA
Human
ELISA
Human
ELISA
Human
ELISA
Human
ELISA
Human
ELISA
Human
ELISA
Human
ELISA
Human
ELISA
Human
ELISA
Human
ELISA
Rat
ELISA
Rat
ELISA
Rat
ELISA
Rat
Immunostaining
Rat
Immunostaining
showing 10 of 10